Status:
UNKNOWN
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
Lead Sponsor:
Assiut University
Conditions:
Antibiotic Resistant Strain
Eligibility:
All Genders
2-50 years
Brief Summary
Klebsiella pneumoniae is an important pathogen that frequently causes nosocomial community-acquired and infections, including pneumonia, urinary tract infections, bloodstream infections, pyogenic live...
Detailed Description
Plasmid mediated carbapenem resistance is mainly due to production of carbapenemase which belong to three classes of β-lactamases, the Ambler class A, B and D β -lactamases, among which the New Delhi ...
Eligibility Criteria
Inclusion
- admitted to intensive care unite
Exclusion
- healthy
Key Trial Info
Start Date :
July 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 7 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03767283
Start Date
July 5 2019
End Date
December 7 2021
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt